Novartis AG (NVS) | Long-term Debt and Solvency Analysis
Solvency ratios also known as long-term debt ratios measure a company's ability to meet long-term obligations.
Ratios (Summary)
Novartis AG, debt and solvency ratios
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Debt to equity | 0.29 | 0.31 | 0.36 | 0.24 | 0.15 | |
| Debt to capital | 0.22 | 0.24 | 0.27 | 0.20 | 0.13 | |
| Interest coverage | 16.53 | 15.34 | 17.91 | 19.01 | 34.00 |
Source: Based on data from Novartis AG Annual Reports
| Ratio | Description | The company |
|---|---|---|
| Debt-to-equity ratio | A solvency ratio calculated as total debt divided by total shareholders' equity. | Novartis AG's debt-to-equity ratio improved from 2010 to 2011 and from 2011 to 2012. |
| Debt-to-capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. | Novartis AG's debt-to-capital ratio improved from 2010 to 2011 and from 2011 to 2012. |
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Novartis AG's interest coverage ratio deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
ADVERTISEMENT
Debt to Equity
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Non-current financial debt | 13,781 | 13,855 | 14,360 | 8,675 | 2,178 | |
| Current financial debt | 5,945 | 6,374 | 8,627 | 5,313 | 5,186 | |
| Total debt | 19,726 | 20,229 | 22,987 | 13,988 | 7,364 | |
| Issued share capital and reserves attributable to Novartis AG shareholders | 69,093 | 65,844 | 63,196 | 57,387 | 50,288 | |
| Debt to Equity, Comparison to Industry | ||||||
| Novartis AG1 | 0.29 | 0.31 | 0.36 | 0.24 | 0.15 | |
| Industry, Health Care | 0.44 | 0.42 | 0.43 | 0.43 | 0.41 | |
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Debt to equity = Total debt ÷ Issued share capital and reserves attributable to Novartis AG shareholders
= 19,726 ÷ 69,093 = 0.29
| Ratio | Description | The company |
|---|---|---|
| Debt-to-equity ratio | A solvency ratio calculated as total debt divided by total shareholders' equity. | Novartis AG's debt-to-equity ratio improved from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Debt to Capital
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Non-current financial debt | 13,781 | 13,855 | 14,360 | 8,675 | 2,178 | |
| Current financial debt | 5,945 | 6,374 | 8,627 | 5,313 | 5,186 | |
| Total debt | 19,726 | 20,229 | 22,987 | 13,988 | 7,364 | |
| Issued share capital and reserves attributable to Novartis AG shareholders | 69,093 | 65,844 | 63,196 | 57,387 | 50,288 | |
| Total capital | 88,819 | 86,073 | 86,183 | 71,375 | 57,652 | |
| Debt to Capital, Comparison to Industry | ||||||
| Novartis AG1 | 0.22 | 0.24 | 0.27 | 0.20 | 0.13 | |
| Industry, Health Care | 0.31 | 0.30 | 0.30 | 0.30 | 0.29 | |
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Debt to capital = Total debt ÷ Total capital
= 19,726 ÷ 88,819 = 0.22
| Ratio | Description | The company |
|---|---|---|
| Debt-to-capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders' equity. | Novartis AG's debt-to-capital ratio improved from 2010 to 2011 and from 2011 to 2012. |
ADVERTISEMENT
Interest Coverage
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | ||||||
| Net income attributable to shareholders of Novartis AG | 9,505 | 9,113 | 9,794 | 8,400 | 8,195 | |
| Add: Net income attributable to non-controlling interests | 113 | 132 | 175 | 54 | 38 | |
| Add: Total interest expense | 724 | 751 | 692 | 551 | 290 | |
| Add: Income tax expense (benefit) | 1,625 | 1,528 | 1,733 | 1,468 | 1,336 | |
| Earnings before interest and tax (EBIT) | 11,967 | 11,524 | 12,394 | 10,473 | 9,859 | |
| Interest Coverage, Comparison to Industry | ||||||
| Novartis AG1 | 16.53 | 15.34 | 17.91 | 19.01 | 34.00 | |
| Industry, Health Care | 15.59 | 15.45 | 13.81 | 19.23 | 17.13 | |
Source: Based on data from Novartis AG Annual Reports
2012 Calculations
1 Interest coverage = EBIT ÷ Interest expense
= 11,967 ÷ 724 = 16.53
| Ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Novartis AG's interest coverage ratio deteriorated from 2010 to 2011 but then slightly improved from 2011 to 2012. |
ADVERTISEMENT





